Alpha Teknova (TKNO) closed at $8.75 on Oct 6, 2026, down 2.8% on the day. The stock is up 26.4% over the past month, up 69.9% over three months, up 130.3% year to date and up 55.1% over the past year. It trades 7.7% below its 52-week high of $9.48 and 358.1% above its 52-week low of $1.91. The close sits above its 50-day moving average ($7.28) and above its 200-day moving average ($4.58).
Yes — the Oct 6, 2026 close of $8.75 is 91.1% above the 200-day average of $4.58.
TKNO closed 7.7% below its 52-week high of $9.48.
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
